{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:59:33Z","timestamp":1767707973010,"version":"3.40.5"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1053\/j.akdh.2023.05.001","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:55:28Z","timestamp":1713671728000},"page":"100-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatorenal Syndrome Type 1: Diagnosis and Treatment"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4599-8850","authenticated-orcid":false,"given":"Justin M.","family":"Belcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.akdh.2023.05.001_bib1","series-title":"Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis and Treatment","first-page":"3","article-title":"Historical notes on ascites in cirrhosis","author":"Arroyo","year":"1999"},{"issue":"90","key":"10.1053\/j.akdh.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-186304000-00002","article-title":"Clinical report of hydro-peritoneum, based on analysis of forty-six cases","volume":"45","author":"Flint","year":"1863","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.akdh.2023.05.001_bib3","first-page":"570","article-title":"A liver and kidney syndrome: clinical, pathological and experimental studies","volume":"55","author":"Helvig","year":"1932","journal-title":"Surg Gynecol Obstet"},{"issue":"6953","key":"10.1053\/j.akdh.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","article-title":"Electrolyte and circulatory changes in terminal liver failure","volume":"271","author":"Hecker","year":"1956","journal-title":"Lancet"},{"key":"10.1053\/j.akdh.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-51-4-759","article-title":"Renal failure in Laennec\u2019s cirrhosis of the liver. I. Description of clinical and laboratory features","volume":"51","author":"Papper","year":"1959","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","article-title":"Renal failure in the patient with cirrhosis. The role of active vasoconstriction","volume":"49","author":"Epstein","year":"1970","journal-title":"Am J Med"},{"issue":"25","key":"10.1053\/j.akdh.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","article-title":"Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease","volume":"280","author":"Koppel","year":"1969","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1053\/j.akdh.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJM197311292892201","article-title":"Recovery from \u201chepatorenal syndrome\u201d after orthotopic liver transplantation","volume":"289","author":"Iwatsuki","year":"1973","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000658-193801000-00010","article-title":"The so-called hepato-renal syndrome","volume":"107","author":"Garlock","year":"1938","journal-title":"Ann Surg"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-1007294","article-title":"Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis","volume":"14","author":"Schrier","year":"1994","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(88)80038-2","article-title":"Pathophysiology of ascites and functional renal failure in cirrhosis","volume":"6","author":"Arroyo","year":"1988","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1053\/j.akdh.2023.05.001_bib13","series-title":"Hepatorenal Syndrome","first-page":"495","article-title":"Presentation of diagnostic criteria of the hepatorenal syndrome","author":"Earley","year":"1979"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/j.akdh.2023.05.001_bib15","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1053\/j.akdh.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"issue":"6","key":"10.1053\/j.akdh.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archinte.168.6.609","article-title":"Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction","volume":"168","author":"Newsome","year":"2008","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archinternmed.2010.514","article-title":"The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death","volume":"171","author":"Ishani","year":"2011","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1053\/j.akdh.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1053\/j.akdh.2023.05.001_bib22","first-page":"S1","article-title":"Kidney Disease: improving Global Outcomes (KDIGO): KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"109","year":"2008","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.akdh.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/hep.27031","article-title":"Reconsidering a \"chopped liver\": the need for improving glomerular filtration rate estimation for hepatic transplantation","volume":"59","author":"Parikh","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"TRIBE-AKI Consortium. Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.akdh.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"North American consortium for study of end-stage liver disease. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.akdh.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/MCG.0b013e31822e8e12","article-title":"Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites","volume":"46","author":"de Carvalho","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J Hepatol"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"TAHRS Investigators. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15403\/jgld.2014.1121.ak1","article-title":"Cross-talk between the liver, heart and kidney-another piece in the puzzle","volume":"23","author":"Krag","year":"2014","journal-title":"J Gastrointest Liver Dis"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/ccr3.3840","article-title":"Venous congestion assessment using point-of-care Doppler ultrasound: Welcome to the future of volume status assessment","volume":"9","author":"Koratala","year":"2021","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000501299","article-title":"Point-of-Care Echocardiography Unveils Misclassification of acute kidney injury as hepatorenal syndrome","volume":"50","author":"Velez","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.akdh.2023.05.001_bib35","article-title":"Invasive hemodynamic parameters in patients with hepatorenal syndrome","volume":"42","author":"Pelayo","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"Suppl 2","key":"10.1053\/j.akdh.2023.05.001_bib36","article-title":"Bioimpedance in hepatorenal syndrome diagnosis- a prospective clinical study","volume":"4","author":"Niculae","year":"2011","journal-title":"NDT Plus"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12664-020-01083-2","article-title":"Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality","volume":"39","author":"Kapoor","year":"2020","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"10.1053\/j.akdh.2023.05.001_bib38","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.ajkd.2010.11.032","article-title":"Clinical applications of biomarkers for acute kidney injury","volume":"57","author":"Belcher","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.akdh.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib42","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000359","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections","volume":"61","author":"Barretto","year":"2014","journal-title":"J Hepatol"},{"issue":"6","key":"10.1053\/j.akdh.2023.05.001_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophile gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"10.1053\/j.akdh.2023.05.001_bib47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5604\/01.3001.0012.0931","article-title":"Urinary neutrophil gelatinase-associated lipocalin in cirrhotic patients with acute kidney injury","volume":"17","author":"Hamdy","year":"2018","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib48","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1111\/hepr.12917","article-title":"Serum adrenomedullin and urinary thromboxane B2 help early categorization of acute kidney injury in decompensated cirrhotic patients: a prospective cohort study","volume":"48","author":"Liu","year":"2018","journal-title":"Hepatology Res"},{"key":"10.1053\/j.akdh.2023.05.001_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/376795","article-title":"Urinary biomarkers of acute kidney injury in patients with liver cirrhosis","volume":"2014","author":"Qasem","year":"2014","journal-title":"ISRN Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2023.05.001_bib50","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1053\/j.akdh.2023.05.001_bib51","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/liv.15069","article-title":"Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome","volume":"41","author":"Sol\u00e9","year":"2021","journal-title":"Liver Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib52","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/hep.32799","article-title":"Diagnostic and prognostic performance of urinary neutrophile gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury","volume":"77","author":"Gambino","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5414\/CN109673","article-title":"Utility of a urine sediment score in hyperbilirubinemia\/hyperbilirubinuria","volume":"92","author":"Poloni","year":"2019","journal-title":"Clin Neph"},{"key":"10.1053\/j.akdh.2023.05.001_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/108139","article-title":"Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study","volume":"2015","author":"Allegretti","year":"2015","journal-title":"Int J Nephrol"},{"issue":"34","key":"10.1053\/j.akdh.2023.05.001_bib55","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4254\/wjh.v8.i34.1497","article-title":"Fractional excretion of sodium in hepatorenal syndrome: clinical and pathological correlation","volume":"8","author":"Alsaad","year":"2016","journal-title":"World J Hepatol"},{"issue":"9","key":"10.1053\/j.akdh.2023.05.001_bib56","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/nep.13226","article-title":"Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study","volume":"24","author":"Jaques","year":"2019","journal-title":"Nephrology"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jceh.2021.09.019","article-title":"Fractional excretion of sodium and urea in differentiating acute kidney injury phenotypes in decompensated cirrhosis","volume":"12","author":"Gowda","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"10.1053\/j.akdh.2023.05.001_bib59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"New in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.29772","article-title":"Fractional excretion of urea: a simple tool for the differential diagnosis of acute kidney injury in cirrhosis","volume":"68","author":"Patidar","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.akdh.2023.05.001_bib61","doi-asserted-by":"crossref","first-page":"627","DOI":"10.34067\/KID.0005692021","article-title":"Concomitant identification of muddy brown granular casts and low fractional excretion of urinary sodium in AKI","volume":"3","author":"Varghese","year":"2022","journal-title":"Kidney360"},{"issue":"11","key":"10.1053\/j.akdh.2023.05.001_bib62","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"issue":"9","key":"10.1053\/j.akdh.2023.05.001_bib65","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","article-title":"Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study","volume":"20","author":"Kiser","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2023.05.001_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JEP.S146034","article-title":"In\u00a0vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2","volume":"10","author":"Jamil","year":"2017","journal-title":"J Exp Pharmacol"},{"issue":"Pt A","key":"10.1053\/j.akdh.2023.05.001_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.phrs.2016.08.027","article-title":"Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile","volume":"113","author":"Colson","year":"2016","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1053\/j.akdh.2023.05.001_bib68","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1111\/liv.14703","article-title":"Terlipressin has stood the test of time: clinical overview in 2020 and future perspectives","volume":"40","author":"Kulkarni","year":"2020","journal-title":"Liver Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2021.08.016","article-title":"Terlipressin and the treatment of hepatorenal syndrome: how the CONFIRM trial moves the story forward","volume":"79","author":"Belcher","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib70","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1053\/j.akdh.2023.05.001_bib71","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1053\/j.akdh.2023.05.001_bib72","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib73","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib74","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.akdh.2023.05.001_bib75","article-title":"Norepinephrine is more effective than midodrine\/octreotide in patients with hepatorenal syndrome-acute kidney injury: a randomized controlled trial","volume":"12","author":"Mahmoud","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1053\/j.akdh.2023.05.001_bib76","first-page":"13","article-title":"Norepinephrine versus terlipressin in patients with type 1 hepatorenal syndrome refractory to treatment with octreotide, midodrine, and albumin: a prospective randomized comparative study","volume":"7","author":"Badawy","year":"2013","journal-title":"Egypt J Cardiothorac Anesth"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000537","article-title":"Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation","volume":"28","author":"Mattos","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib78","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.akdh.2023.05.001_bib79","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib81","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.akdh.2023.05.001_bib82","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/apt.15836","article-title":"Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome","volume":"52","author":"Moore","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1053\/j.akdh.2023.05.001_bib83","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/apt.17195","article-title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1053\/j.akdh.2023.05.001_bib84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","article-title":"Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome- A systematic review and meta-analysis","volume":"50","author":"Song","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1053\/j.akdh.2023.05.001_bib85","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1053\/j.akdh.2023.05.001_bib86","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2215\/CJN.09600912","article-title":"Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib87","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-200035988","article-title":"The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis","volume":"26","author":"Capling","year":"2004","journal-title":"Ren Fail"},{"issue":"1","key":"10.1053\/j.akdh.2023.05.001_bib88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.05.001_bib89","doi-asserted-by":"crossref","first-page":"819","DOI":"10.34067\/KID.0005182020","article-title":"Renal recovery and mortality risk among patients with hepatorenal syndrome receiving chronic maintenance dialysis","volume":"2","author":"McAllister","year":"2021","journal-title":"Kidney360"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T05:31:24Z","timestamp":1713677484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813923000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2949813923000575"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.05.001","relation":{},"ISSN":["2949-8139"],"issn-type":[{"type":"print","value":"2949-8139"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatorenal Syndrome Type 1: Diagnosis and Treatment","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}